
ONCIMMUNE HOLDINGS PLC — Investor Relations & Filings
Oncimmune Holdings PLC is a precision medicine and immunodiagnostics company specializing in the discovery and application of antibody and autoantibody biomarker signatures. The company's core technology is the ImmunoINSIGHTS™ platform, an advanced analytical engine for immune profiling. This platform utilizes a proprietary library of over 9,000 human antigens, bead-based multiplexed immunoassay technology, and machine learning algorithms to generate biological insights from minimal sample volumes. Oncimmune applies its expertise across therapeutic areas including immuno-oncology, autoimmune diseases, and infectious diseases. It provides biomarker discovery services, targeted panels, and advanced bioinformatics to support pharmaceutical and biotechnology partners in developing more effective and targeted treatments and diagnostics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Appointment of Administrators & Nomad Resignation | 2025-03-26 | English | |
| Holding(s) in Company | 2025-03-19 | English | |
| Intention to Appoint Administrators and Suspension | 2025-03-17 | English | |
| Block Listing Return | 2025-03-14 | English | |
| Result of GM | 2025-03-10 | English | |
| Result of AGM | 2025-02-27 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 6770030 | Appointment of Administrators & Nomad Resignation | 2025-03-26 | English | ||
| 5594783 | Holding(s) in Company | 2025-03-19 | English | ||
| 5593384 | Intention to Appoint Administrators and Suspension | 2025-03-17 | English | ||
| 5592659 | Block Listing Return | 2025-03-14 | English | ||
| 5589562 | Result of GM | 2025-03-10 | English | ||
| 5584360 | Result of AGM | 2025-02-27 | English | ||
| 46831556 | Group of companies' accounts made up to 2024-08-31 | 2025-02-25 | English | ||
| 5582904 | Strategic update | 2025-02-24 | English | ||
| 5580577 | Holding(s) in Company | 2025-02-18 | English | ||
| 5578356 | Block Listing Return | 2025-02-12 | English | ||
| 5578364 | Posting of Notice of General Meeting | 2025-02-12 | English | ||
| 5577315 | Final Results | 2025-02-10 | English | ||
| 5574782 | Holding(s) in Company | 2025-02-04 | English | ||
| 5574198 | Notice of Annual General Meeting | 2025-02-03 | English | ||
| 5573375 | Trading Update | 2025-01-31 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for ONCIMMUNE HOLDINGS PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aptose Biosciences Inc.
Clinical-stage company developing targeted precision medici…
|
APS | CA | Professional, scientific and te… |
|
APURES CO., LTD.
Biotech firm providing MICROPIG models, bio-resources, and …
|
149300 | KR | Professional, scientific and te… |
|
Aran Research & Development (1982) Ltd.
A product design and development firm providing services fr…
|
ARAN | IL | Professional, scientific and te… |
|
Arch Biopartners Inc.
Developing novel drugs for acute kidney injury (AKI) and ch…
|
ARCH | CA | Professional, scientific and te… |
|
ARCHER MATERIALS LIMITED
Develops semiconductor devices for quantum computing and me…
|
AXE | AU | Professional, scientific and te… |
|
ARGENICA THERAPEUTICS LIMITED
Clinical-stage developer of neuroprotective drugs for acute…
|
AGN | AU | Professional, scientific and te… |
|
ARIUS Research Inc.
Discovery and development of targeted antibody therapeutics…
|
ARI | CA | Professional, scientific and te… |
|
AROVELLA THERAPEUTICS LIMITED
Develops off-the-shelf iNKT cell therapies for blood cancer…
|
ALA | AU | Professional, scientific and te… |
|
Artiva Biotherapeutics, Inc.
Develops allogeneic, off-the-shelf NK cell therapies for ca…
|
ARTV | US | Professional, scientific and te… |
|
ARVINAS, INC.
Clinical-stage biopharma developing therapeutics based on t…
|
ARVN | US | Professional, scientific and te… |
ONCIMMUNE HOLDINGS PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7820/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7820 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7820 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7820 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7820}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ONCIMMUNE HOLDINGS PLC (id: 7820)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.